Papers
4
Total Citations
48
H-Index
3
About
Dr. Anbang He is a pioneering urologic surgeon and researcher at the forefront of robotic-assisted surgery, with a particular focus on single-port and remote surgical systems. His major contributions center on evaluating the safety and efficacy of novel robotic platforms—most notably the Shurui single-port (SR-SP) system—in complex urologic oncology procedures. In his landmark 2023 study on single-port robot-assisted radical prostatectomy (20 citations), Dr. He demonstrated the feasibility of this minimally invasive approach for prostate cancer, while his parallel work on partial nephrectomy (17 citations) extended these benefits to renal tumors. He has also explored the frontiers of telemedicine, conducting a prospective comparative study on 5G-remote radical prostatectomy (2025, 3 citations), and has applied robotic platforms to rare vascular tumors, as in his report on inferior vena cava hemangioma resection using the Toumai system (8 citations). Collectively, his work has garnered over 48 citations, establishing him as a key figure in advancing next-generation robotic surgery and expanding access to high-precision, remote surgical care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4